Abstract
The phospholamban (PLN) pathogenic gene variant, p.Arg14del (PLN-R14del), can lead to dilated and arrhythmogenic cardiomyopathy, resulting in heart failure. PLN-R14del cardiomyopathy has been conceptualized as a disease caused by sarco/endoplasmic reticulum calcium adenosine triphosphatase 2a (SERCA2a) superinhibition. However, recent studies raised controversy regarding the effect of PLN-R14del on SERCA activity and revealed a prominent role for abnormal PLN protein distribution and sarco/endoplasmic reticulum disorganization as underlying disease mechanism. Strategies targeting sarco/endoplasmic reticulum malformation may, therefore, prove more effective than SERCA activity modulation. This review reassesses the disease mechanisms of PLN-R14del cardiomyopathy and emphasizes the importance of dissecting the underlying molecular mechanisms to uncover targets for innovative treatments.
Original language | English |
---|---|
Pages (from-to) | 1041-1052 |
Number of pages | 12 |
Journal | JACC: Basic to Translational Science |
Volume | 9 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug-2024 |
Keywords
- aggregation
- cardiomyopathy
- disease mechanism
- p.Arg14del
- phospholamban
- sarcoplasmic reticulum
- SERCA